Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Eribulin [Halaven] Use For the Treatment of Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Palliative and Oncology Care Model in Breast Cancer
- Status
- COMPLETED
- Phase
- NA
PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I Study of MLN0128 and MLN8237 in Patients With Advanced Solid Tumors and Metastatic Triple-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot Study
- Status
- COMPLETED
- Phase
- NA
Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments
- Status
- COMPLETED
- Phase
- N/A
Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Phase IB Study to Evaluate RAD1901 on the Availability of Estrogen Receptor Binding Sites in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases
- Status
- COMPLETED
- Phase
- PHASE1
Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving Trastuzumab
- Status
- COMPLETED
- Phase
- PHASE1